review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1542-0124(12)70082-4 |
P698 | PubMed publication ID | 17508117 |
P2860 | cites work | Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women | Q24537414 |
Cataract surgery in patients with dry eyes | Q77160020 | ||
Prevalence of treated dry eye disease in a managed care population | Q77299205 | ||
Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency | Q77752013 | ||
Oral and ocular sicca symptoms and findings are prevalent in systemic lupus erythematosus | Q78083039 | ||
Ocular findings after bone marrow transplantation in a pediatric population | Q78112906 | ||
Xerophthalmia and undiagnosed eating disorder | Q78551482 | ||
Validation and repeatability of a short questionnaire for dry eye syndrome | Q79826261 | ||
Utility assessment and dry eye disease | Q79839756 | ||
The reliability and validity of McMonnies Dry Eye Index | Q79960357 | ||
Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions | Q80243890 | ||
UK patients with primary Sjögren's syndrome are at increased risk from clinical depression | Q80567002 | ||
The economic burden of dry eye: a conceptual framework and preliminary assessment | Q80902614 | ||
Comparing the discriminative validity of two generic and one disease-specific health-related quality of life measures in a sample of patients with dry eye | Q81603538 | ||
Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjögren's syndrome-related dry eye | Q24794134 | ||
Effect of androgen deficiency on the human meibomian gland and ocular surface | Q28141302 | ||
Is complete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface? | Q28189953 | ||
Prevalence of dry eye syndrome among US women | Q28196875 | ||
Health-related quality of life in primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. | Q30587348 | ||
Decrease in tear secretion and corneal sensitivity after laser in situ keratomileusis | Q30658995 | ||
Symptoms of dry eye and recurrent erosion syndrome after refractive surgery | Q30664347 | ||
Clinical applications of the Shack-Hartmann aberrometer | Q30829411 | ||
Effects of laser in situ keratomileusis on tear production, clearance, and the ocular surface | Q30993840 | ||
Dry eye after laser in situ keratomileusis | Q30994248 | ||
Refractive surgery in the United States Army, 2000-2003. | Q31146172 | ||
Chronic dry eye and regression after laser in situ keratomileusis for myopia | Q33200474 | ||
Dry eye after LASIK: comparison of outcomes for Asian and Caucasian eyes | Q33213607 | ||
Effect of artificial tears on visual acuity | Q33227891 | ||
The incidence and risk factors for developing dry eye after myopic LASIK. | Q33234379 | ||
Correlations in a change in aqueous tear evaporation with a change in relative humidity and the impact | Q33237641 | ||
Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials | Q33848201 | ||
The frequency of ocular symptoms during spectacle and daily soft and rigid contact lens wear | Q33877384 | ||
Dry eye in diabetic patients | Q34402818 | ||
Computer vision syndrome: a review. | Q34413625 | ||
A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada | Q34441489 | ||
The epidemiology of dry eye in Melbourne, Australia | Q34471837 | ||
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group | Q34523084 | ||
Ocular manifestations of hepatitis C virus infection | Q35004233 | ||
Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. | Q35006592 | ||
Eye complaints in the office environment: precorneal tear film integrity influenced by eye blinking efficiency | Q35501892 | ||
Fatigue in primary Sjögren's syndrome: is there a link with the fibromyalgia syndrome? | Q35548974 | ||
Abnormal tear dynamics and symptoms of eyestrain in operators of visual display terminals | Q35560954 | ||
Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation | Q35619625 | ||
Impact of dry eye syndrome on vision-related quality of life | Q35741609 | ||
Ocular complications of hypovitaminosis a after bariatric surgery | Q36122942 | ||
Discontinuation of contact lens wear: a survey. | Q39418209 | ||
Results of a population-based questionnaire on the symptoms and lifestyles associated with dry eye. | Q39437533 | ||
Prevalence of dry eye among the elderly | Q39457390 | ||
The Eye Care Technology Forum. Impacting eye care cost and effectiveness | Q40811761 | ||
Review of external ocular disease associated with aids and HIV infection | Q41052694 | ||
Ocular complications of bone marrow transplantation | Q42053758 | ||
Impaired functional visual acuity of dry eye patients | Q42668504 | ||
Use of the dry eye questionnaire to measure symptoms of ocular irritation in patients with aqueous tear deficient dry eye. | Q42684410 | ||
Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators | Q42686675 | ||
Hormone replacement therapy and dry eye syndrome | Q43788868 | ||
Sjögren's syndrome: a community-based study of prevalence and impact. | Q43867416 | ||
Use of eye care and associated charges among the Medicare population: 1991-1998. | Q44017596 | ||
Fatigue in daily life in patients with primary Sjögren's syndrome and systemic lupus erythematosus | Q44061788 | ||
Outcomes of phacoemulsification in patients with dry eye. | Q44088095 | ||
Low-dose aspirin and risk of cataract and subtypes in a randomized trial of U.S. physicians | Q44166406 | ||
Nutrient intake in women with primary and secondary Sjögren's syndrome | Q44305227 | ||
Androgen control of gene expression in the rabbit meibomian gland. | Q44339203 | ||
Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. | Q44473550 | ||
The Relationship between Habitual Patient-Reported Symptoms and Clinical Signs among Patients with Dry Eye of Varying Severity | Q44631963 | ||
Dry eye signs and symptoms in women with premature ovarian failure | Q44760300 | ||
The application of a new continuous functional visual acuity measurement system in dry eye syndromes | Q45284546 | ||
Utility of studying the ocular surface in patients with acne vulgaris treated with oral isotretinoin: a randomized controlled trial | Q46401468 | ||
Prevalence and severity of symptomatic dry eyes in Hispanics | Q46425842 | ||
Potential role of disrupted lacrimal acinar cells in dry eye during pregnancy. | Q46434850 | ||
Ocular surface disorders and tear function changes in nodulo-cystic acne | Q46466067 | ||
Psychometric properties of the National Eye Institute-Refractive Error Quality of Life instrument | Q46818783 | ||
Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. | Q50494234 | ||
Tear film, contact lens, and patient-related factors associated with contact lens-related dry eye. | Q50735512 | ||
Sensitivity and specificity of a screening questionnaire for dry eye. | Q50881188 | ||
Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. | Q50933029 | ||
Frequency of and factors associated with contact lens dissatisfaction and discontinuation. | Q51080966 | ||
Laser in situ keratomileusis-induced (presumed) neurotrophic epitheliopathy. | Q51356308 | ||
Self-reported dry eye disease across refractive modalities. | Q51454973 | ||
Adverse environmental health effects of ultra-low relative humidity indoor air. | Q51791445 | ||
Symptoms prevalence among office employees and associations to building characteristics. | Q51829668 | ||
The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample. | Q51934443 | ||
Utility assessment among patients with dry eye disease. | Q53379868 | ||
Complete Androgen Insensitivity Syndrome | Q55982482 | ||
Long-term complications of total body irradiation in adults | Q58051911 | ||
Ocular, nasal, dermal and general symptoms among commercial airline crews | Q58308487 | ||
Dry Eye and Dry Mouth in the Elderly | Q58760236 | ||
Corneal complications after cataract surgery in patients with rheumatoid arthritis | Q68119990 | ||
Symptomatology of HEMA contact lens wear | Q69449530 | ||
Test and symptoms in keratoconjunctivitis sicca and their correlation | Q71848212 | ||
Correlations between nutrient intake and the polar lipid profiles of meibomian gland secretions in women with Sjögren's syndrome | Q73071817 | ||
Responses of contact lens wearers to a dry eye survey | Q73401158 | ||
Reliability and validity of the Ocular Surface Disease Index | Q73801624 | ||
Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study | Q73920520 | ||
Prevalence of and risk factors for dry eye syndrome | Q74298539 | ||
Vegan diet and vitamin A deficiency | Q76346882 | ||
P433 | issue | 2 | |
P921 | main subject | epidemiology | Q133805 |
eye disease | Q3041498 | ||
P304 | page(s) | 93-107 | |
P577 | publication date | 2007-04-01 | |
P1433 | published in | The Ocular Surface | Q15764153 |
P1476 | title | The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007) | |
P478 | volume | 5 |
Q38076540 | 2. Contact lens care and ocular surface homeostasis |
Q43118320 | A Crosslinked HA-Based Hydrogel Ameliorates Dry Eye Symptoms in Dogs |
Q37732321 | A Metabolome-Wide Study of Dry Eye Disease Reveals Serum Androgens as Biomarkers |
Q37676992 | A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye. |
Q34627003 | A Randomized, Controlled Treatment Trial of Eyelid-Warming Therapies in Meibomian Gland Dysfunction |
Q41442733 | A comparative review of Haute Autorité de Santé and National Institute for Health and Care Excellence health technology assessments of Ikervis® to treat severe keratitis in adult patients with dry eye disease which has not improved despite treatment |
Q37204567 | A field test of Web-based screening for dry eye disease to enhance awareness of eye problems among general Internet users: a latent strategy to promote health |
Q33837188 | A novel TRPM8 agonist relieves dry eye discomfort |
Q57803593 | A novel elastin-like polypeptide drug carrier for cyclosporine A improves tear flow in a mouse model of Sjögren's syndrome |
Q54222666 | A randomized study of the efficacy and safety of 0.1% cyclosporine A cationic emulsion in treatment of moderate to severe dry eye. |
Q34364536 | A review of quality of life measures in dry eye questionnaires |
Q35176597 | A review on recent advances in dry eye: Pathogenesis and management |
Q38605127 | A unique lineage gives rise to the meibomian gland |
Q36445561 | Accelerated Restoration of Ocular Surface Health in Dry Eye Disease by Self-Retained Cryopreserved Amniotic Membrane |
Q38497754 | Acupuncture for dry eye: a multicentre randomised controlled trial with active comparison intervention (artificial tear drop) using a mixed method approach protocol |
Q33552734 | Acupuncture for dry eye: a randomised controlled trial protocol |
Q34277339 | Acupuncture for the treatment of dry eye: a multicenter randomised controlled trial with active comparison intervention (artificial teardrops). |
Q26863317 | Acupuncture therapy is more effective than artificial tears for dry eye syndrome: evidence based on a meta-analysis |
Q35773063 | Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease |
Q34087380 | Age-related changes of the ocular surface: a hospital setting-based retrospective study |
Q34114336 | Aging: a predisposition to dry eyes. |
Q41889066 | Air exposure induced characteristics of dry eye in conjunctival tissue culture |
Q46199306 | Alx4 relays sequential FGF signaling to induce lacrimal gland morphogenesis |
Q57814418 | An Eyelid Warming Device for the Management of Meibomian Gland Dysfunction |
Q41094456 | An In Vitro Model for the Ocular Surface and Tear Film System |
Q60961948 | An experimental study of amniotic lacrimal duct stents in the treatment of perimenopausal female rabbits with dry eye |
Q34043708 | Androgen deficiency and dry eye syndrome in the aging male |
Q94553034 | Anti-inflammatory effects of glycine thymosin β4 eye drops in experimental dry eye |
Q27026893 | Antimicrobial compounds in tears |
Q47932134 | Application of Scanning Electron Microscopy With Energy-Dispersive X-Ray Spectroscopy for Analyzing Ocular Surface Particles on Schirmer Strips |
Q64269461 | Apricot Kernel Extract and Amygdalin Inhibit Urban Particulate Matter-Induced Keratoconjunctivitis Sicca |
Q36861178 | Are higher blood mercury levels associated with dry eye symptoms in adult Koreans? A population-based cross-sectional study |
Q35071714 | Assessment of dry eye signs and symptoms and ocular tolerance of a preservative-free lacrimal substitute (Hylabak®) versus a preserved lacrimal substitute (Systane®) used for 3 months in patients after LASIK. |
Q64054722 | Association between Dry Eye Disease and Psychological Stress among Paramedical Workers in Korea |
Q90574523 | Association between dry eye symptoms and signs |
Q33713187 | Association of dry eye disease with psychiatric or neurological disorders in elderly patients |
Q26781979 | Associations between signs and symptoms of dry eye disease: a systematic review |
Q35242945 | Associations between subjective happiness and dry eye disease: a new perspective from the Osaka study |
Q36625074 | Autoimmunity at the ocular surface: pathogenesis and regulation |
Q37071969 | Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression |
Q48146337 | Autologous Platelet-Rich Plasma Eye Drops for the Treatment of Post-LASIK Chronic Ocular Surface Syndrome |
Q26773937 | Biomaterials and Tissue Engineering Strategies for Conjunctival Reconstruction and Dry Eye Treatment |
Q36499692 | Blueberry Component Pterostilbene Protects Corneal Epithelial Cells from Inflammation via Anti-oxidative Pathway |
Q48002135 | Bulbar conjunctival microvascular responses in dry eye. |
Q38712838 | Burning Eye Syndrome: Do Neuropathic Pain Mechanisms Underlie Chronic Dry Eye? |
Q39960842 | Characteristics of Ocular Pain Complaints in Patients With Idiopathic Dry Eye Symptoms. |
Q37458867 | Characteristics of respondents with glaucoma and dry eye in a national panel survey |
Q38370253 | Characteristics of symptoms experienced by persons with dry eye disease while driving in China |
Q57476626 | Characterization of expressed human meibum using hyperspectral stimulated Raman scattering microscopy |
Q46752293 | Children with dry eye type conditions may report less severe symptoms than adult patients |
Q40959262 | Chronic dry eye in photorefractive keratectomy and laser in situ keratomileusis: Manifestations, incidence, and predictive factors |
Q35591446 | Chronic migraine is associated with reduced corneal nerve fiber density and symptoms of dry eye. |
Q28468440 | Clinical Evaluation of a Royal Jelly Supplementation for the Restoration of Dry Eye: A Prospective Randomized Double Blind Placebo Controlled Study and an Experimental Mouse Model |
Q37397701 | Clinical Trial of Thermal Pulsation (LipiFlow) in Meibomian Gland Dysfunction With Preteatment Meibography |
Q36313759 | Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study |
Q38733230 | Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting |
Q35647454 | Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes |
Q49844544 | Comparison Between Viscous Teardrops and Saline Solution to Fill Orthokeratology Contact Lenses Before Overnight Wear. |
Q33553643 | Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis |
Q35944109 | Comparison of Early Changes in Ocular Surface and Inflammatory Mediators between Femtosecond Lenticule Extraction and Small-Incision Lenticule Extraction |
Q35798154 | Comparison of Two Questionnaires for Dry Eye Symptom Assessment: The Ocular Surface Disease Index and the Symptom Assessment in Dry Eye |
Q33811761 | Comparison of camel tear proteins between summer and winter |
Q87474365 | Comparison of deep anterior lamellar keratoplasty and penetrating keratoplasty with respect to postoperative corneal sensitivity and tear film function |
Q35035637 | Comparison of dry eye and corneal sensitivity between small incision lenticule extraction and femtosecond LASIK for myopia |
Q36173201 | Comparison of ocular-surface disease index questionnaire, tearfilm break-up time, and Schirmer tests for the evaluation of the tearfilm in computer users with and without dry-eye symptomatology |
Q49168665 | Comparison of the Efficacy of Carboxymethylcellulose 0.5%, Hydroxypropyl-guar Containing Polyethylene Glycol 400/Propylene Glycol, and Hydroxypropyl Methyl Cellulose 0.3% Tear Substitutes in Improving Ocular Surface Disease Index in Cases of Dry Eye |
Q37187277 | Comparison of two methods for composite score generation in dry eye syndrome |
Q26752848 | Comprehensive Review of the Literature on Existing Punctal Plugs for the Management of Dry Eye Disease |
Q36495510 | Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation |
Q36556824 | Corneal Dendritic Cell Density Is Associated with Subbasal Nerve Plexus Features, Ocular Surface Disease Index, and Serum Vitamin D in Evaporative Dry Eye Disease |
Q34881185 | Corneal Lymphatics: Role in Ocular Inflammation as Inducer and Responder of Adaptive Immunity |
Q36630948 | Corneal Mechanical Thresholds Negatively Associate With Dry Eye and Ocular Pain Symptoms |
Q35678783 | Corneal sensitivity following lacrimal gland excision in the rat. |
Q36377091 | Correlation between corneal innervation and inflammation evaluated with confocal microscopy and symptomatology in patients with dry eye syndromes: a preliminary study |
Q59796099 | Cross-linked hyaluronic acid gel occlusive device for the treatment of dry eye syndrome |
Q38235721 | Current Approach to Dry Eye Disease. |
Q35572113 | Cyclosporine 0.05% ophthalmic emulsion for dry eye in Korea: a prospective, multicenter, open-label, surveillance study |
Q54487191 | Cyclosporine in ocular surface inflammation. |
Q35570541 | Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence |
Q39492528 | Cytotoxicity assays of new artificial tears containing 2-methacryloyloxyethyl phosphorylcholine polymer for ocular surface cells |
Q30448957 | Decrease in hyperosmotic stress-induced corneal epithelial cell apoptosis by L-carnitine |
Q42432373 | Decreased tear volume in patients with metabolic syndrome: the Osaka study |
Q92465209 | Defining the needs and preferences of patients with dry eye disease |
Q38926020 | Depression and anxiety in dry eye disease: a systematic review and meta-analysis |
Q24169750 | Depression, post-traumatic stress disorder, and dry eye syndrome: a study utilizing the national United States Veterans Affairs administrative database |
Q36259467 | Depressive Symptoms in Patients With Dry Eye Disease: A Case-Control Study Using the Beck Depression Inventory |
Q33362899 | Desiccating stress decreases apical corneal epithelial cell size--modulation by the metalloproteinase inhibitor doxycycline |
Q47554801 | Development and evaluation of a measure of patient-reported symptoms of Blepharitis. |
Q91945885 | Diagnosing the Dry Eye Syndrome in modern society and among patients with glaucoma: a prospective study |
Q34092386 | Diagnosing the severity of dry eye: a clear and practical algorithm |
Q91405343 | Diagnostic Test Efficacy of Meibomian Gland Morphology and Function |
Q39352252 | Diagnostic procedures and management of dry eye. |
Q37027074 | Differences in Central Corneal Thickness between Spectral Domain-Optical Coherence Tomography and Ultrasound Pachymetry in Patients with Dry Eye Disease |
Q60529880 | Digital eye strain: prevalence, measurement and amelioration |
Q35629673 | Diquafosol ophthalmic solution 3 %: a review of its use in dry eye. |
Q37536295 | Discordant Dry Eye Disease (An American Ophthalmological Society Thesis). |
Q37242107 | Do Cyclosporine A, an IL-1 Receptor Antagonist, Uridine Triphosphate, Rebamipide, and/or Bimatoprost Regulate Human Meibomian Gland Epithelial Cells? |
Q34243991 | Does estrogen deficiency cause lacrimal gland inflammation and aqueous-deficient dry eye in mice? |
Q93109216 | Dry Eye Analysis: A Citation Network Study |
Q57171838 | Dry Eye Assessment and Management (DREAM©) Study: Study design and baseline characteristics |
Q41816277 | Dry Eye Disease following Refractive Surgery: A 12-Month Follow-Up of SMILE versus FS-LASIK in High Myopia |
Q90415394 | Dry Eye Disease in Routine Rheumatology Practice |
Q36829070 | Dry Eye Profiles in Patients with a Positive Elevated Surface Matrix Metalloproteinase 9 Point-of-Care Test Versus Negative Patients. |
Q36321217 | Dry Eye Syndrome and Allergic Conjunctivitis in the Pediatric Population |
Q86483090 | Dry eye and tear film functions in patients with psoriasis |
Q35796783 | Dry eye disease and depression-anxiety-stress: A hospital-based case control study in Turkey |
Q36799601 | Dry eye disease and microbial keratitis: is there a connection? |
Q34273384 | Dry eye disease: A review of diagnostic approaches and treatments |
Q36916372 | Dry eye disease: an immune-mediated ocular surface disorder |
Q33870075 | Dry eye in LASIK patients |
Q41536179 | Dry eye specific quality of life in veterans using glaucoma drops |
Q47639135 | Dry eye syndrome: developments and lifitegrast in perspective |
Q26852044 | Dry eye: an inflammatory ocular disease |
Q36038395 | Dual-Polymer Drops, Contact Lens Comfort, and Lid Wiper Epitheliopathy |
Q26770830 | Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature Review |
Q36323797 | Edaravone protects against hyperosmolarity-induced oxidative stress and apoptosis in primary human corneal epithelial cells |
Q37678617 | Effect of a Mediterranean dietary pattern and vitamin D levels on Dry Eye syndrome |
Q37250982 | Effect of chronic anti-glaucoma medications and trabeculectomy on tear osmolarity |
Q37485814 | Effect of dihydrotestosterone on the expression of mucin 1 and the activity of Wnt signaling in mouse corneal epithelial cells |
Q37245147 | Effect of human milk as a treatment for dry eye syndrome in a mouse model |
Q36120878 | Effect of topically applied epithelial sodium channel inhibitors on tear production in normal mice and in mice with induced aqueous tear deficiency |
Q35655084 | Effectiveness and relevant factors of 2% rebamipide ophthalmic suspension treatment in dry eye. |
Q37464380 | Effectiveness and tolerability of dietary supplementation with a combination of omega-3 polyunsaturated fatty acids and antioxidants in the treatment of dry eye symptoms: results of a prospective study |
Q37280480 | Effectiveness of sodium hyaluronate eye gel in patients with dry eye disease: a multi-centre, open label, uncontrolled study. |
Q35732401 | Effects of Dry Eye Therapies on Environmentally Induced Ocular Surface Disease |
Q36380238 | Effects of Insulin and High Glucose on Human Meibomian Gland Epithelial Cells |
Q36692399 | Effects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress |
Q36290093 | Effects of Topical Fucosyl-Lactose, a Milk Oligosaccharide, on Dry Eye Model: An Example of Nutraceutical Candidate |
Q37716339 | Effects of adjuvant omega-3 fatty acid supplementation on dry eye syndrome following cataract surgery: A randomized clinical trial |
Q35214116 | Effects of corneal nerve density on the response to treatment in dry eye disease |
Q40997622 | Efficacy and safety of retinol palmitate ophthalmic solution in the treatment of dry eye: a Japanese Phase II clinical trial |
Q35507058 | Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial |
Q35532014 | Efficacy of 1% carboxymethylcellulose sodium for treating dry eye after phacoemulsification: results from a multicenter, open-label, randomized, controlled study |
Q33734626 | Efficacy of a crosslinked hyaluronic acid-based hydrogel as a tear film supplement: a masked controlled study |
Q35233288 | Efficacy of a new prescription-only medical food supplement in alleviating signs and symptoms of dry eye, with or without concomitant cyclosporine A. |
Q54256507 | Enzymes of urea synthesis are expressed at the ocular surface, and decreased urea in the tear fluid is associated with dry-eye syndrome. |
Q49893002 | Establishing and characterizing lacrispheres from human lacrimal gland for potential clinical application. |
Q34130406 | Establishing human lacrimal gland cultures with secretory function. |
Q92501705 | Establishment of long-term serum-free culture for lacrimal gland stem cells aiming at lacrimal gland repair |
Q35008077 | Establishment of the mild, moderate and severe dry eye models using three methods in rabbits |
Q92340824 | Evaluation of Corneal Damage After Lacrimal Gland Excision in Male and Female Mice |
Q37717435 | Evaluation of Ocular Surface Disease in Asian Patients with Primary Angle Closure |
Q36362131 | Evaluation of a Novel Artificial Tear in the Prevention and Treatment of Dry Eye in an Animal Model |
Q47098857 | Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye. |
Q47778585 | Evaluation of a novel dry eye model induced by oral administration of finasteride |
Q34764807 | Evaluation of the adhesive properties of the cornea by means of optical coherence tomography in patients with meibomian gland dysfunction and lacrimal tear deficiency. |
Q36072190 | Evaporation and Hydrocarbon Chain Conformation of Surface Lipid Films |
Q47638923 | Evidence that dry eye is a comorbid pain condition in a U.S. veteran population |
Q35805082 | Expert opinion in the management of aqueous Deficient Dry Eye Disease (DED). |
Q33585574 | Expression Profiling of Nonpolar Lipids in Meibum From Patients With Dry Eye: A Pilot Study |
Q35919611 | Expression of SIRT1 and oxidative stress in diabetic dry eye. |
Q44255306 | Expression patterns of conjunctival mucin 5AC and aquaporin 5 in response to acute dry eye stress |
Q38625299 | Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome |
Q58105209 | Factors Associated with Dry Eye Symptoms in Elderly Koreans: the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 |
Q39378640 | Fingerprick autologous blood: a novel treatment for dry eye syndrome |
Q37123269 | Frequency and risk factors associated with dry eye in patients attending a tertiary care ophthalmology center in Mexico City |
Q36626322 | Growth Hormone Influence on the Morphology and Size of the Mouse Meibomian Gland. |
Q33861286 | HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease |
Q35030126 | Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients |
Q36558017 | High Levels of 17β-Estradiol Are Associated with Increased Matrix Metalloproteinase-2 and Metalloproteinase-9 Activity in Tears of Postmenopausal Women with Dry Eye |
Q37259818 | How ocular surface disease impacts the glaucoma treatment outcome |
Q36247483 | Human Lacrimal Gland Gene Expression |
Q33623540 | Hydroxypropyl cellulose ophthalmic inserts (lacrisert) reduce the signs and symptoms of dry eye syndrome and improve patient quality of life |
Q36302713 | Hyperosmolarity-induced lipid droplet formation depends on ceramide production by neutral sphingomyelinase 2. |
Q33686417 | Image-guided evaluation and monitoring of treatment response in patients with dry eye disease |
Q35958194 | Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life |
Q88268544 | Impact of lifestyle intervention on dry eye disease in office workers: a randomized controlled trial |
Q24169749 | Impact of ocular surface symptoms on quality of life in a United States Veterans Affairs population |
Q33621122 | Impression cytology implicates cell autophagy in aqueous deficiency dry eye. |
Q52598288 | Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A-loaded micelles: formulation, in vitro and in vivo studies. |
Q36898923 | In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis). |
Q24337461 | Insulin-like factor 3 promotes wound healing at the ocular surface |
Q36058512 | Inter-examiner reliability in meibomian gland dysfunction assessment. |
Q41540895 | Interdisciplinary, Comprehensive Oral and Ocular Evaluation of Patients with Primary Sjögren's Syndrome |
Q28364856 | Interobserver variability of an open-source software for tear meniscus height measurement |
Q35632214 | Intra-observer and inter-observer repeatability of ocular surface interferometer in measuring lipid layer thickness |
Q41817907 | Investigating the potential benefits of a new artificial tear formulation combining two polymers |
Q37393926 | Is household air pollution a risk factor for eye disease? |
Q35690598 | Isotonic Glycerol and Sodium Hyaluronate Containing Artificial Tear Decreases Conjunctivochalasis after One and Three Months: A Self-Controlled, Unmasked Study. |
Q56775795 | Knowledge, attitude, and practice of dry eye treatment by institutional Chinese physicians in Singapore |
Q33686673 | Korean guidelines for the diagnosis and management of dry eye: development and validation of clinical efficacy. |
Q64122014 | Latent Sensitization in a Mouse Model of Ocular Neuropathic Pain |
Q37457256 | Lipidomic analysis of human tear fluid reveals structure-specific lipid alterations in dry eye syndrome |
Q50793003 | Local ocular surface parameters in patients with systemic celiac disease. |
Q59034455 | Long-term effects of cataract surgery on tear film parameters |
Q86904838 | Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye |
Q47437122 | Loss of β Epithelial Sodium Channel Function in Meibomian Glands Produces Pseudohypoaldosteronism 1-Like Ocular Disease in Mice |
Q41862908 | Lower Vitamin D Level and Distinct Tear Cytokine Profile Were Observed in Patients with Mild Dry Eye Signs but Exaggerated Symptoms |
Q26772031 | Making the diagnosis of Sjögren's syndrome in patients with dry eye |
Q24609136 | Mapping the entire human corneal nerve architecture |
Q58599953 | Matrix Metalloproteinase 9 Point-of-Care Immunoassay Result Predicts Response to Topical Cyclosporine Treatment in Dry Eye Disease |
Q37060242 | Meibography: A review of techniques and technologies |
Q33737599 | Meibomian Gland Dysfunction in Type 2 Diabetic Patients. |
Q41493127 | Meibomian gland features in a Norwegian cohort of patients with primary Sjögren´s syndrome |
Q34701978 | Meibomian lipid films and the impact of temperature |
Q34063529 | Meibum lipid composition in Asians with dry eye disease |
Q80347912 | Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007) |
Q47093888 | Mitochondria-Targeted Antioxidant SkQ1 Prevents Anesthesia-Induced Dry Eye Syndrome. |
Q35799409 | Modulation of HLA-DR in dry eye patients following 30 days of treatment with a lubricant eyedrop solution |
Q37641857 | Molecular Profiling of the Developing Lacrimal Gland Reveals Putative Role of Notch Signaling in Branching Morphogenesis |
Q36625520 | Morphologic alterations of the palpebral conjunctival epithelium in a dry eye model |
Q36642407 | Neuropathic Ocular Pain due to Dry Eye is Associated with Multiple Comorbid Chronic Pain Syndromes |
Q35196826 | Neuropathic ocular pain: an important yet underevaluated feature of dry eye. |
Q47739620 | Neuropathic pain and dry eye. |
Q40062999 | Neuropathic symptoms of the ocular surface: dryness, pain, and itch |
Q47566745 | Neuropathic-Like Ocular Pain and Nonocular Comorbidities Correlate With Dry Eye Symptoms |
Q35085293 | Neurostimulation of the lacrimal nerve for enhanced tear production |
Q38058002 | New agents for treating dry eye syndrome. |
Q47228449 | Novel Insight Into the Role of CFTR in Lacrimal Gland Duct Function in Mice |
Q27021208 | Novel Therapy to Treat Corneal Epithelial Defects: A Hypothesis with Growth Hormone |
Q35163639 | Nutritional supplements for dry eye syndrome |
Q30490212 | Objective Assessment of Ocular Surface Response to Contact Lens Wear in Presbyopic Contact Lens Wearers of Asian Descent |
Q48145043 | Ocular Demodex folliculorum: prevalence and associated symptoms in an Irish population |
Q92310446 | Ocular Surface Changes in Prostaglandin Analogue-Treated Patients |
Q35015847 | Ocular iontophoresis of EGP-437 (dexamethasone phosphate) in dry eye patients: results of a randomized clinical trial |
Q38774962 | Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice |
Q53663447 | Ocular surface changes after strabismus surgery with different incisions. |
Q35067567 | Ocular surface disease in posttrabeculectomy/mitomycin C patients |
Q36683576 | Ocular surface parameters in older male veterans |
Q37551864 | Ocular surface symptoms in veterans returning from operation Iraqi freedom and operation enduring freedom |
Q24198944 | Omega-3 and omega-6 polyunsaturated fatty acids for dry eye syndrome |
Q33798707 | Omega-3 fatty acids in dry eye and corneal nerve regeneration after refractive surgery |
Q33439876 | On the lipid composition of human meibum and tears: comparative analysis of nonpolar lipids |
Q39738019 | One man's poison is another man's meat: using azithromycin-induced phospholipidosis to promote ocular surface health |
Q53836361 | One-year efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease. |
Q33623447 | Ophthalmologist perceptions regarding treatment of moderate to severe dry eye: results of a physician survey. |
Q40017537 | Optic toxicity in radiation treatment of meningioma: a retrospective study in 213 patients |
Q42702543 | Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye. |
Q24186110 | Over the counter (OTC) artificial tear drops for dry eye syndrome |
Q24203616 | Over the counter (OTC) artificial tear drops for dry eye syndrome |
Q35010238 | Patient reported differences in dry eye disease between men and women: impact, management, and patient satisfaction |
Q61808996 | Patient-reported severity of dry eye and quality of life in diabetes |
Q36242214 | Patients With Dry Eye Disease and Low Subbasal Nerve Density Are at High Risk for Accelerated Corneal Endothelial Cell Loss |
Q40775085 | Patients with more severe symptoms of neuropathic ocular pain report more frequent and severe chronic overlapping pain conditions and psychiatric disease |
Q40953862 | Perceptions of dry eye disease management in current clinical practice |
Q52558847 | Phosphosulindac is efficacious in an improved concanavalin A-based rabbit model of chronic dry eye disease. |
Q91905513 | Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease |
Q31007979 | Pre-corneal tear film thickness in humans measured with a novel technique |
Q37453768 | Predicted phenotypes of dry eye: proposed consequences of its natural history. |
Q59791491 | Presence of Immune Complexes of IgG/IgM Bound to B2-glycoprotein I Is Associated With Non-criteria Clinical Manifestations in Patients With Antiphospholipid Syndrome |
Q64244731 | Prevalence and Determinants of Dry Eye Disease among 40 Years and Older Population of Riyadh (Except Capital), Saudi Arabia |
Q47547213 | Prevalence and Risk Factors of self-reported dry eye in Brazil using a short symptom questionnaire |
Q36537077 | Prevalence and associated factors of dry eye: Our experience in patients above 40 years of age at a Tertiary Care Center |
Q49584452 | Prevalence and risk factors of dry eye disease in North India: Ocular surface disease index-based cross-sectional hospital study. |
Q33964406 | Prevalence and risk factors of dry eye syndrome in a United States veterans affairs population |
Q34438211 | Prevalence of and risk factors for dry eye symptom in mainland china: a systematic review and meta-analysis |
Q33720070 | Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies |
Q99411668 | Prevalence of dry eye disease in the elderly: A protocol of systematic review and meta-analysis |
Q28073073 | Prevalence of dry eye disease in visual display terminal workers: a systematic review and meta-analysis |
Q34383016 | Prevalence of dry eye syndrome after a three-year exposure to a clean room |
Q37423611 | Prevalence of ocular surface disease symptoms and risk factors in group of university students in Monterrey, Mexico |
Q36846620 | Quantification of MUCIN 1, cell surface associated and MUCIN16, cell surface associated proteins in tears and conjunctival epithelial cells collected from postmenopausal women |
Q52889830 | Randomized Controlled Crossover Trial Comparing the Impact of Sham or Intranasal Tear Neurostimulation on Conjunctival Goblet Cell Degranulation. |
Q64066727 | Rebamipide ophthalmic solution modulates the ratio of T helper cell 17/regulatory T cells in dry eye disease mice |
Q36780058 | Recovery of radiation-induced dry eye and corneal damage by pretreatment with adenoviral vector-mediated transfer of erythropoietin to the salivary glands in mice |
Q35579883 | Reduced Corneal Endothelial Cell Density in Patients With Dry Eye Disease |
Q47138584 | Regenerative Therapies in Dry Eye Disease: From Growth Factors to Cell Therapy |
Q50034049 | Relation Between Dietary Essential Fatty Acid Intake and Dry Eye Disease and Meibomian Gland Dysfunction in Postmenopausal Women. |
Q37046020 | Relationships among Tear Film Stability, Osmolarity, and Dryness Symptoms |
Q36835236 | Repeatability and Reproducibility of Noninvasive Keratograph 5M Measurements in Patients with Dry Eye Disease |
Q33505732 | Reproducibility of tear meniscus measurement by Fourier-domain optical coherence tomography: a pilot study |
Q90249521 | Resolvin D1, but not resolvin E1, transactivates the epidermal growth factor receptor to increase intracellular calcium and glycoconjugate secretion in rat and human conjunctival goblet cells |
Q34206822 | Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model |
Q64899282 | Retrospective Observational Study on Rebamipide Ophthalmic Suspension on Quality of Life of Dry Eye Disease Patients. |
Q33825538 | Safety and efficacy of cyclosporine in the treatment of chronic dry eye. |
Q41911324 | Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension |
Q37616823 | Salivary defense system alters in vegetarian. |
Q49594250 | Satisfaction and convenience of using terpenoid-impregnated eyelid wipes and teaching method in people without blepharitis. |
Q35472653 | Sensitization of trigeminal brainstem pathways in a model for tear deficient dry eye |
Q38598996 | Sex differences in the effect of aging on dry eye disease |
Q34128729 | Shotgun lipidomic analysis of human meibomian gland secretions with electrospray ionization tandem mass spectrometry. |
Q37404304 | Single Nucleotide Polymorphisms in the BDNF, VDR, and DNASE 1 Genes in Dry Eye Disease Patients: A Case-Control Study |
Q36812082 | Small-molecule CFTR activators increase tear secretion and prevent experimental dry eye disease |
Q37359864 | Smoking and the risk of dry eye: a Meta-analysis |
Q41489266 | Sodium Hyaluronate in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-Analysis |
Q24282614 | Solvent/Detergent Virally Inactivated Serum Eye Drops Restore Healthy Ocular Epithelium in a Rabbit Model of Dry-Eye Syndrome |
Q34070100 | Spatial epidemiology of dry eye disease: findings from South Korea |
Q47134597 | Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye. |
Q35070541 | Symptom burden of patients with dry eye disease: a four domain analysis |
Q37900496 | Systane lubricant eye drops in the management of ocular dryness |
Q36604784 | Tear Film Break-up Time in Bipolar Disorder. |
Q41181275 | Tear Film Steroid Profiling in Dry Eye Disease by Liquid Chromatography Tandem Mass Spectrometry. |
Q90523884 | Tear eicosanoids in healthy people and ocular surface disease |
Q34590930 | The Association between Dry Eye Disease and Physical Activity as well as Sedentary Behavior: Results from the Osaka Study |
Q45326881 | The Association of Dry Eye Symptom Severity and Comorbid Insomnia in US Veterans |
Q50665912 | The Conjunctiva-Associated Lymphoid Tissue in Chronic Ocular Surface Diseases. |
Q28547448 | The Effect of Tear Supplementation on Ocular Surface Sensations during the Interblink Interval in Patients with Dry Eye |
Q61452739 | The Effects of Lighting Problems on Eye Symptoms among Cleanroom Microscope Workers |
Q38569837 | The Future of Dry Eye Treatment: A Glance into the Therapeutic Pipeline |
Q51772900 | The Human Eye Proteome Project: Updates on an Emerging Proteome. |
Q36039088 | The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye |
Q38724515 | The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eye |
Q41405231 | The Prospective Health Assessment of Cataract Patients' Ocular Surface (PHACO) study: the effect of dry eye. |
Q47639063 | The Relationship Between Ocular Itch, Ocular Pain, and Dry Eye Symptoms (An American Ophthalmological Society Thesis). |
Q34385610 | The aging lacrimal gland: changes in structure and function. |
Q35085765 | The association between dry eye disease and depression and anxiety in a large population-based study |
Q28601496 | The association of sleep quality with dry eye disease: the Osaka study |
Q34159564 | The combined effect of azithromycin and insulin-like growth factor-1 on cultured human meibomian gland epithelial cells |
Q48169068 | The correlation between plasma osmolarity and tear osmolarity |
Q36107326 | The effect of Vaccinium uliginosum extract on tablet computer-induced asthenopia: randomized placebo-controlled study |
Q90418082 | The efficacy and safety of qiming granule in dry eye disease: Protocol for systematic review and meta-analysis |
Q34511150 | The heritability of dry eye disease in a female twin cohort |
Q49487998 | The improvement of dry eye after cataract surgery by intraoperative using ophthalmic viscosurgical devices on the surface of cornea: The results of a consort-compliant randomized controlled trial. |
Q36961065 | The influence of 13-cis retinoic acid on human meibomian gland epithelial cells |
Q34769313 | The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee |
Q34769309 | The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD |
Q37781259 | The ocular surface in thyroid diseases |
Q88362505 | The prevalence of meibomian gland dysfunction, tear film and ocular surface parameters in an Austrian dry eye clinic population |
Q48250853 | The relation of functional visual acuity measurement methodology to tear functions and ocular surface status |
Q35208749 | The relationship between clinical signs and dry eye symptoms. |
Q37801992 | The tear film and the optical quality of the eye. |
Q36177590 | The use of fluorescent quenching in studying the contribution of evaporation to tear thinning |
Q92855863 | The use of preservatives in dry eye drops |
Q36224854 | Therapeutic efficacy of fibroblast growth factor 10 in a rabbit model of dry eye. |
Q46689617 | Time course of ocular surface and lacrimal gland changes in a new scopolamine-induced dry eye model |
Q37721598 | Tissue resident memory T cells in the human conjunctiva and immune signatures in human dry eye disease |
Q90567703 | Total Tear IgE Levels Correlate with Allergenic and Irritating Environmental Exposures in Individuals with Dry Eye |
Q36331804 | Traffic-related air pollution and spectacles use in schoolchildren |
Q37460389 | Transcription, translation, and function of lubricin, a boundary lubricant, at the ocular surface |
Q35688387 | Transduction, tropism, and biodistribution of AAV vectors in the lacrimal gland |
Q55009490 | Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study. |
Q46443810 | Typical questions from the rheumatologist to the ophthalmologist and cooperating radiologist |
Q42126622 | Use of adipose-derived mesenchymal stem cells in keratoconjunctivitis sicca in a canine model |
Q58769015 | Variations of dry eye disease prevalence by age, sex and geographic characteristics in China: a systematic review and meta-analysis |
Q37737411 | Vision Screening of Ophthalmic Nursing Staff in a Tertiary Eye Care Hospital: Outcomes and ocular healthcare-seeking behaviours. |
Q41522747 | What can photophobia tell us about dry eye? |
Q87404739 | [Comparison of the OSDI and SPEED questionnaires for the evaluation of dry eye disease in clinical routine] |
Q88884763 | [Diagnosis and treatment of the watering eye] |
Q85963889 | [Eyelid hygiene for contact lens wearers with blepharitis. Comparative investigation of treatment with baby shampoo versus phospholipid solution] |
Q85524713 | [Influence of dry eye syndrome on glaucoma diagnostic procedures] |
Q36872931 | ω-3 Tear Film Lipids Correlate With Clinical Measures of Dry Eye. |
Search more.